AAAAAA

   
Results: 1-25 |
Results: 25
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma
Authors: Lee, SH Shin, MS Kim, HS Lee, HK Park, WS Kim, SY Lee, JH Han, SY Park, JY Oh, RR Kang, CS Kim, KM Jang, JJ Nam, SW Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma, ONCOGENE, 20(3), 2001, pp. 399-403
Expression of Fas and Fas-related molecules in human hepatocellular carcinoma
Authors: Lee, SH Shin, MS Lee, HS Bae, JH Lee, HK Kim, HS Kim, SY Jang, JJ Joo, M Kang, YK Park, WS Park, JY Oh, RR Han, SY Lee, JH Kim, SH Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Expression of Fas and Fas-related molecules in human hepatocellular carcinoma, HUMAN PATH, 32(3), 2001, pp. 250-256
Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma
Authors: Park, WS Oh, RR Park, JY Kim, PJ Shin, MS Lee, JH Kim, HS Lee, SH Kim, SY Park, YG An, WG Kim, HS Jang, JJ Yoo, NJ Lee, JY
Citation: Ws. Park et al., Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma, J PATHOLOGY, 193(4), 2001, pp. 483-490
Somatic mutations in the death domain of the Fas (Apo-I/CD95) gene in gastric cancer
Authors: Park, WS Oh, RR Kim, YS Park, JY Lee, SH Shin, MS Kim, SY Kim, PJ Lee, HK Yoo, NJ Lee, JY
Citation: Ws. Park et al., Somatic mutations in the death domain of the Fas (Apo-I/CD95) gene in gastric cancer, J PATHOLOGY, 193(2), 2001, pp. 162-168
RNA polymerase sigma factor that blocks morphological differentiation by Streptomyces coelicolor
Authors: Gehring, AM Yoo, NJ Losick, R
Citation: Am. Gehring et al., RNA polymerase sigma factor that blocks morphological differentiation by Streptomyces coelicolor, J BACT, 183(20), 2001, pp. 5991-5996
Inactivating mutations of KILLER/DR5 gene in gastric cancers
Authors: Park, WS Lee, JH Shin, MS Park, JY Kim, HS Kim, YS Park, CH Lee, SK Lee, SH Lee, SN Kim, H Yoo, NJ Lee, JY
Citation: Ws. Park et al., Inactivating mutations of KILLER/DR5 gene in gastric cancers, GASTROENTY, 121(5), 2001, pp. 1219-1225
Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers
Authors: Shin, MS Kim, HS Lee, SH Park, WS Kim, SY Park, JY Lee, JH Lee, SK Lee, SN Jung, SS Han, JY Kim, H Lee, JY Yoo, NJ
Citation: Ms. Shin et al., Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers, CANCER RES, 61(13), 2001, pp. 4942-4946
Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas
Authors: Park, WS Oh, RR Kim, YS Park, JY Shin, MS Lee, HK Lee, SH Yoo, NJ Lee, JY
Citation: Ws. Park et al., Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas, APMIS, 108(3), 2000, pp. 195-200
Mapping of a new target region of allelic loss at 21q22 in primary gastriccancers
Authors: Park, WS Oh, RR Park, JY Yoo, NJ Lee, SH Shin, MS Kim, SY Kim, YS Lee, JH Kim, HS An, WG Lee, JY
Citation: Ws. Park et al., Mapping of a new target region of allelic loss at 21q22 in primary gastriccancers, CANCER LETT, 159(1), 2000, pp. 15-21
Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar
Authors: Lee, SH Shin, MS Kim, HS Park, WS Kim, SY Jang, JJ Rhim, KJ Jang, J Lee, HK Park, JY Oh, RR Han, SY Lee, JH Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar, J INVES DER, 114(1), 2000, pp. 122-126
Expression of Fas ligand in activated T cells is regulated by c-Myc
Authors: Brunner, T Kasibhatla, S Pinkoski, MJ Frutschi, C Yoo, NJ Echeverri, F Mahboubi, A Green, DR
Citation: T. Brunner et al., Expression of Fas ligand in activated T cells is regulated by c-Myc, J BIOL CHEM, 275(13), 2000, pp. 9767-9772
Somatic mutations of the trefoil factor family 1 gene in gastric cancer
Authors: Park, WS Oh, RR Park, JY Lee, JH Shin, MS Kim, HS Lee, HK Kim, YS Kim, SY Lee, SH Yoo, NJ Lee, JY
Citation: Ws. Park et al., Somatic mutations of the trefoil factor family 1 gene in gastric cancer, GASTROENTY, 119(3), 2000, pp. 691-698
A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer
Authors: Park, WS Park, JY Oh, RR Yoo, NJ Lee, SH Shin, MS Lee, HK Han, SY Kim, S Kim, SY Choi, C Kim, PJ Oh, ST Lee, JY
Citation: Ws. Park et al., A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer, CANCER RES, 60(1), 2000, pp. 70-73
Transitional cell carcinoma expresses high levels of Fas ligand in vivo
Authors: Lee, SH Lee, JY Park, WS Kim, SY Jang, JJ Yoo, NJ
Citation: Sh. Lee et al., Transitional cell carcinoma expresses high levels of Fas ligand in vivo, BJU INT, 83(6), 1999, pp. 698-702
Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer
Authors: Lee, SH Shin, MS Park, WS Kim, SY Kim, HS Han, JY Park, GS Dong, SM Pi, JH Kim, CS Kim, SH Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer, ONCOGENE, 18(25), 1999, pp. 3754-3760
Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues
Authors: Lee, SH Shin, MS Park, WS Kim, SY Kim, HS Lee, JH Han, SY Lee, HK Park, JY Oh, RR Jang, JJ Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues, APMIS, 107(12), 1999, pp. 1101-1108
Immunohistochemical analysis of Fas ligand expression in normal human tissues
Authors: Lee, SH Shin, MS Park, WS Kim, SY Dong, SM Lee, HK Park, JY Oh, RR Jang, JJ Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Immunohistochemical analysis of Fas ligand expression in normal human tissues, APMIS, 107(11), 1999, pp. 1013-1019
In vivo expression of soluble Fas and Fap-1: Possible mechanisms of Fas resistance in human hepatoblastomas
Authors: Lee, SH Shin, MS Lee, JY Park, WS Kim, SY Jang, JJ Dong, SM Na, EY Kim, CS Kim, SH Yoo, NJ
Citation: Sh. Lee et al., In vivo expression of soluble Fas and Fap-1: Possible mechanisms of Fas resistance in human hepatoblastomas, J PATHOLOGY, 188(2), 1999, pp. 207-212
Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas
Authors: Lee, SH Shin, MS Kim, HS Park, WS Kim, SY Lee, HK Park, JY Oh, RR Jang, JJ Park, KM Han, JY Kang, CS Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas, CANCER RES, 59(22), 1999, pp. 5674-5677
Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers
Authors: Lee, SH Shin, MS Kim, HS Lee, HK Park, WS Kim, SY Lee, JH Han, SY Park, JY Oh, RR Jang, JJ Han, JY Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers, CANCER RES, 59(22), 1999, pp. 5683-5686
Somatic mutations in the kinase domain of the MET/hepatocyte growth factorreceptor gene in childhood hepatocellular carcinomas
Authors: Park, WS Dong, SM Kim, SY Na, EY Shin, MS Pi, JH Kim, BJ Bae, JH Hong, YK Lee, KS Lee, SH Yoo, NJ Jang, JJ Pack, S Zhuang, ZP Schmidt, L Zbar, B Lee, JY
Citation: Ws. Park et al., Somatic mutations in the kinase domain of the MET/hepatocyte growth factorreceptor gene in childhood hepatocellular carcinomas, CANCER RES, 59(2), 1999, pp. 307-310
Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer
Authors: Park, WS Oh, RR Park, JY Lee, SH Shin, MS Kim, YS Kim, SY Lee, HK Kim, PJ Oh, ST Yoo, NJ Lee, JY
Citation: Ws. Park et al., Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer, CANCER RES, 59(17), 1999, pp. 4257-4260
Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder
Authors: Lee, SH Shin, MS Park, WS Kim, SY Dong, SM Pi, JH Lee, HK Kim, HS Jang, JJ Kim, CS Kim, SH Lee, JY Yoo, NJ
Citation: Sh. Lee et al., Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder, CANCER RES, 59(13), 1999, pp. 3068-3072
Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
Authors: Shin, MS Park, WS Kim, SY Kim, HS Kang, SJ Song, KY Park, JY Dong, SM Pi, JH Oh, RR Lee, JY Yoo, NJ Lee, SH
Citation: Ms. Shin et al., Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma, AM J PATH, 154(6), 1999, pp. 1785-1791
Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo
Authors: Lee, SH Jang, JJ Lee, JY Kim, SY Park, WS Kim, CS Kim, SH Yoo, NJ
Citation: Sh. Lee et al., Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo, APMIS, 106(11), 1998, pp. 1035-1040
Risultati: 1-25 |